Placebo response in the treatment of panic disorder

Bulletin of the Menninger Clinic

Volumn 60, Issue 2 SUPPL., 1996, Pages

  Hirschfeld, Robert M A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HUMAN; PANIC; REVIEW;

BENZODIAZEPINES; CONTROLLED CLINICAL TRIALS; HUMANS; PANIC DISORDER; PLACEBO EFFECT; PLACEBOS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029979893     PISSN: 00259284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ballenger, J. C., Burrows, G. D., Dupont, R. L. Jr., Lesser, I. M., Noyes, R., Jr., Pecknold, J. C., Rifkin, A., & Swinson, R. P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413-422.
2. Black, D. W., Wesner, R., Bowers, W., & Gabel, J. ( 1993). A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry, 50, 44-50.
3. Cross-National Collaborative Panic Study, Second Phase Investigators. (1992). Drug treatment of panic disorder: Comparative efficacy of alprazolam, imipramine, and placebo. British Journal of Psychiatry, 160, 191-202.
4. Dunbar, G., Steiner, M., Oakes, I., Gergel, I., Burnham, D., & Weadon, D. E. (1995, September/October). A fixed dose study of paroxetine (10 mg, 20 mg, 40 mg) and placebo in the treatment of panic disorder. Paper presented at a meeting of the European College of Neuropsychopharmacology, Venice, Italy.
5. Hales, R. E., Yudofsky, S. C., & Talbott, J. A. (Eds.). (1994). Textbook of psychiatry. Washington, DC: American Psychiatric Press.
6. Hollander, E., Simeon, D., & Gorman, J. (1994). Anxiety disorders. In R. E. Hales, S. C. Yudorfsky, &: J. A. Talbott (Eds.), Textbook of psychiatry (2nd ed., pp. 495-563). Washington, DC: American Psychiatric Press.
7. Janicak, P. G., Davis, J. M., Preskorn, S. H., & Ayd, F. J., Jr. (1993). Treatment with antidepressants. In D. C. Retford (Ed.), Principles and practice of psychopharmacotherapy (pp. 209-292). Baltimore: William's and Wilkin's.
8. Keller, M. B., & Baker, L. A. (1992). The clinical course of panic disorder and depression. Journal of Clinical Psychiatry, 53(3, SuppL.), 5-8.
9. Keller, M. B., & Hanks, D. L. (1993). Course and outcome in panic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 551-570.
10. Keller, M. B., Lavori, P. W., Mueller, T. I., Endicott, J., Coryell, W., Hirschfeld, R. M. A., & Shea, T. (1992). Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects. Archives of General Psychiatry, 49, 809-816.
11. Lasagna, L. (1994). Decision processes in establishing the efficacy and safety of psychotropic agents. In R. F. Prien & D. S. Robinson (Eds.), Clinical evaluation of psychotropic drugs: Principles and guidelines (pp. 13-28). New York: Raven.
12. LeCrubier, Y., Bakker, A., & Judge, R. (1994, September). A double-blind placebo controlled study of paroxetine and clomipramine in the treatment of panic disorder. Paper presented at a meeting of the Association of European Psychiatrists, Copenhagen, Denmark.
13. Noyes R., Jr., Garvey, M. J., & Cook, B. L. (1989). Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. Journal of Affective Disorders, 16, 249-257.
14. Noyes, R., Jr., Reich, J., & Christiansen, J. (1990). Outcome of panic disorder: Relationship to diagnostic subtypes and comorbidity. Archives of General Psychiatry, 47, 809-818.
15. Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995). Paroxetine in the treatment of panic disorder: A randomized, double-blind, placebo-controlled study. British Journal of Psychiatry, 167, 374-379.
16. Slaap, B. R., van Vliet, I. M., Westenberg, H. G. M., & Den Boer, J. A. (1995). Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report). Journal of Affective Disorders, 33, 31-38.
17. Tesar, G. E., Rosenbaum, J. F., Pollack, M. H., Otto, M. W., Sachs, G. S., Herman, J. B., Cohen, L. S., & Spier, S. A. (1991). Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. Journal of Clinical Psychiatry, 52, 69-76.